TEMPUS ARIES: A Biobank Registry Platform Study in Oncology

Tempus AI

Status: Enrolling

Conditions: Cancer

Study type: Observational

Funder types: Industry

Identifiers

NCT06207032

Pro00076336 (Other Identifier)

TP-CA-007

Details and patient eligibility

About

This study is a non-interventional, multicenter, multicohort evaluation of participants with cancer who will undergo longitudinal plasma ctDNA biomarker profiling at specific time points in addition to standard of care therapy.

Enrollment: 500 estimated patients

Sex: All

Ages: 18 to 99 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. ≥18 years of age
2. Willing to participate in the research
3. Able to provide informed consent
4. Must be diagnosed with cancer

Exclusion criteria

1. Not willing or able to have additional blood samples collected

Trial design

500 participants in 6 patient groups

Cohort 001: KRAS mutated CRC

Description:

No intervention.

Cohort 002: KRAS mutated PDAC

Description:

No intervention.

Cohort 003: KRAS mutated NSCLC

Description:

No intervention.

Cohort 004: Gastric 1L Plus

Description:

No intervention.

Cohort 005: mCRPC 1L Plus

Description:

No intervention.

Cohort 006: Pan Tumor ADCs

Description:

No intervention.